Detalhe da pesquisa
1.
[Fecal Microbiota Transfer (FMT) in Germany - Status and Perspective]. / Fäkaler Mikrobiota-Transfer (FMT) in Deutschland Status und Perspektive.
Z Gastroenterol
; 62(4): 490-499, 2024 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-37187187
2.
Menthacarin for long-term treatment of functional dyspepsia - Results from a clinical trial follow-up.
Z Gastroenterol
; 61(3): 257-267, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697065
3.
[Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany]. / Reizdarmbehandlung mit Lactobacillus plantarum 299v: Längere Einnahme verstärkt Behandlungserfolg Ergebnisse einer nichtinterventionellen Studie.
Z Gastroenterol
; 59(2): 125-134, 2021 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-33556972
4.
[Bile acid diarrhea, stepchild of chronic diarrhea - prevalence, diagnosis and treatment. Update 2021]. / Chologene Diarrhö, Stiefkind der chronischen Diarrhö Prävalenz, Diagnostik und Therapie. Update 2021.
Z Gastroenterol
; 59(6): 580-591, 2021 Jun.
Artigo
em Alemão
| MEDLINE | ID: mdl-33634438
5.
[Patient perception and approval of fecal microbiota transplantation (FMT) as an alternative treatment option for ulcerative colitis]. / Akzeptanz des fäkalen Mikrobiota-Transfers (Stuhltransplantation) als alternative Therapie bei Patienten mit Colitis ulcerosa.
Z Gastroenterol
; 57(3): 296-303, 2019 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-30861553
6.
[Eosinophilic Esophagitis Update: New Guidelines of the European Study Group EUREOS]. / Eosinophile Ösophagitis Update 2017: Neue Leitlinien der europäischen Studiengruppe EUREOS.
Laryngorhinootologie
; 98(11): 764-775, 2019 Nov.
Artigo
em Alemão
| MEDLINE | ID: mdl-31739353
7.
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives.
Bioessays
; 38(4): 344-54, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26817719
8.
[Eosinophilic Esophagitis Update: New Guidelines of the European Study Group EUREOS]. / Eosinophile Ösophagitis Update 2017: Neue Leitlinien der europäischen Studiengruppe EUREOS.
Z Gastroenterol
; 56(2): 139-150, 2018 02.
Artigo
em Alemão
| MEDLINE | ID: mdl-29121691
9.
[Psychosomatics in gastroenterology - statement of the Work Group for Psychosomatics in Gastroenterology of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)]. / Psychosomatik in der Gastroenterologie Stellungnahme der Arbeitsgemeinschaft Psychosomatik in der Gastroenterologie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).
Z Gastroenterol
; 56(6): 684-689, 2018 06.
Artigo
em Alemão
| MEDLINE | ID: mdl-29890563
10.
[Interpretation und performance of high-resolution esophageal manometry: Recommendations of the German Association of Neurogastroenterology and Motility (DGNM) and the German Association of Gastroenterology, Digestive and Metabolic Diseases (DGVS)]. / Interpretation und Durchführung der hochauflösenden Ösophagusmanometrie: Empfehlungen der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) sowie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselerkrankungen (DGVS).
Z Gastroenterol
; 56(11): 1378-1408, 2018 Nov.
Artigo
em Alemão
| MEDLINE | ID: mdl-30419581
11.
Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome.
Am J Gastroenterol
; 112(6): 933-939, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28349993
12.
Evaluating the Multitarget Effects of Combinations through Multistep Clustering of Pharmacological Data: the Example of the Commercial Preparation Iberogast.
Planta Med
; 83(14-15): 1130-1140, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28859216
13.
Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.
Handb Exp Pharmacol
; 239: 343-362, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28161834
14.
Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM).
Z Gastroenterol
; 60(2): 192-218, 2022 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-35148561
15.
Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.
Wien Med Wochenschr
; 167(7-8): 160-168, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424994
16.
Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview.
Pharmacology
; 96(1-2): 76-85, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26139425
17.
Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases.
J Pharmacol Exp Ther
; 348(3): 401-9, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24345466
18.
Bladder function in a cannabinoid receptor type 1 knockout mouse.
BJU Int
; 113(1): 144-51, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24053792
19.
An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS).
Exp Brain Res
; 232(8): 2563-70, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24792504
20.
Cannabis finds its way into treatment of Crohn's disease.
Pharmacology
; 93(1-2): 1-3, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24356243